VPIM
Vanguard Personalized Indexing Management’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9M | Buy |
234,706
+5,771
| +3% | +$267K | 0.12% | 138 |
|
|
2025
Q1 | $14M | Buy |
228,935
+27,702
| +14% | +$1.69M | 0.21% | 85 |
|
|
2024
Q4 | $11.4M | Buy |
201,233
+40,542
| +25% | +$2.29M | 0.17% | 91 |
|
|
2024
Q3 | $8.31M | Buy |
160,691
+43,742
| +37% | +$2.26M | 0.13% | 125 |
|
|
2024
Q2 | $4.71M | Sell |
116,949
-13,032
| -10% | -$525K | 0.09% | 188 |
|
|
2024
Q1 | $7.05M | Sell |
129,981
-11,388
| -8% | -$618K | 0.15% | 118 |
|
|
2023
Q4 | $7.25M | Buy |
141,369
+47,067
| +50% | +$2.42M | 0.19% | 90 |
|
|
2023
Q3 | $5.47M | Sell |
94,302
-16,870
| -15% | -$979K | 0.16% | 96 |
|
|
2023
Q2 | $7.11M | Sell |
111,172
-8,237
| -7% | -$527K | 0.22% | 75 |
|
|
2023
Q1 | $8.28M | Sell |
119,409
-2,866
| -2% | -$199K | 0.29% | 55 |
|
|
2022
Q4 | $8.8M | Buy |
122,275
+10,294
| +9% | +$741K | 0.36% | 45 |
|
|
2022
Q3 | $7.96M | Buy |
111,981
+527
| +0.5% | +$37.5K | 0.36% | 42 |
|
|
2022
Q2 | $8.58M | Buy |
111,454
+31,781
| +40% | +$2.45M | 0.4% | 35 |
|
|
2022
Q1 | $5.82M | Buy |
79,673
+46,204
| +138% | +$3.37M | 0.28% | 63 |
|
|
2021
Q4 | $2.09M | Sell |
33,469
-12,745
| -28% | -$795K | 0.12% | 155 |
|
|
2021
Q3 | $2.74M | Buy |
46,214
+4,816
| +12% | +$285K | 0.25% | 72 |
|
|
2021
Q2 | $2.77M | Buy |
41,398
+20,713
| +100% | +$1.38M | 0.29% | 56 |
|
|
2021
Q1 | $1.31M | Buy |
20,685
+2,416
| +13% | +$153K | 0.2% | 106 |
|
|
2020
Q4 | $1.13M | Buy |
18,269
+2,406
| +15% | +$149K | 0.25% | 88 |
|
|
2020
Q3 | $956K | Buy |
15,863
+3,816
| +32% | +$230K | 0.27% | 81 |
|
|
2020
Q2 | $708K | Buy |
12,047
+1,702
| +16% | +$100K | 0.32% | 69 |
|
|
2020
Q1 | $577K | Buy |
+10,345
| New | +$577K | 0.34% | 84 |
|